Hirtle Callaghan & CO LLC Medtronic PLC Transaction History

Hirtle Callaghan & CO LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 14, 2019	SELL	$82.45 - $93.79 $366,820 - $417,271	-4,449 Closed	0 $0
Q2 2018 Jul 23, 2018	SELL	$77.48 - $87.83 $270,870 - $307,053	-3,496 Reduced 44.0%	4,449 $381,000
Q4 2017 Jan 17, 2018	SELL	$76.93 - $83.5 $31,079 - $33,734	-404 Reduced 4.84%	7,945 $642,000
Q3 2017 Nov 13, 2017	BUY	$77.71 - $84.6 $648,800 - $706,325	8,349	8,349 $649,000

2,288

1.02B

8.05M

7.19M

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $111B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

Get notified when there are updates to the investment portfolio of Hirtle Callaghan & CO LLC, based on Form 13F filings with the SEC.

Stay updated on Hirtle Callaghan & CO LLC with notifications on news.